CYP2D6 Genotype and Adjuvant Tamoxifen.

CYP2D6 Genotype and Adjuvant Tamoxifen.
Clin Pharmacol Ther. 2014 Aug;96(2):138-40
Authors: Berry DA
Abstract
A study by Province et al. for the International Tamoxifen Pharmacogenomics Consortium (ITPC) appeared in a recent issue of this journal.(1) In addition to discussing this study and biomarker studies in general, I provide an overall assessment of the evidence regarding testing for CYP2D6 in making clinical decisions regarding the use of tamoxifen in adjuvant breast cancer.
PMID: 25056391 [PubMed - in process]

Source: Clinical Breast Cancer - July 28, 2014 Category: Cancer & Oncology Authors: Berry DA Tags: Clin Pharmacol Ther Source Type: research